You are here

  • Home
  • Archive
  • Volume 5, Issue 8
  • Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension

Article info

Article menu

Download PDFPDF

XML
Cardiovascular medicine
Protocol
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension

Authors

  • Morris J Brown Clinical Pharmacology Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK Trial Executive for the British Hypertension Society's PATHWAY Programme of Trials Steering Committee for the British Hypertension Society's PATHWAY Programme of Trials PubMed articlesGoogle scholar articles
  • Bryan Williams Trial Executive for the British Hypertension Society's PATHWAY Programme of Trials Steering Committee for the British Hypertension Society's PATHWAY Programme of Trials Institute of Cardiovascular Sciences, University College London, London, UK PubMed articlesGoogle scholar articles
  • Thomas M MacDonald Trial Executive for the British Hypertension Society's PATHWAY Programme of Trials Steering Committee for the British Hypertension Society's PATHWAY Programme of Trials Medicines Monitoring Unit, Medical Research Institute, University of Dundee, Dundee, Tayside, UK PubMed articlesGoogle scholar articles
  • Mark Caulfield Steering Committee for the British Hypertension Society's PATHWAY Programme of Trials William Harvey Institute, QMUL, London, UK PubMed articlesGoogle scholar articles
  • J Kennedy Cruickshank Cardiovascular Medicine & Diabetes, King's College London, London, UK PubMed articlesGoogle scholar articles
  • Gordon McInnes Institute of Cardiovascular Medical Sciences, Western Infirmary, London, UK PubMed articlesGoogle scholar articles
  • Peter Sever Steering Committee for the British Hypertension Society's PATHWAY Programme of Trials Centre of Circulatory Health, Imperial College, London, UK PubMed articlesGoogle scholar articles
  • David J Webb Steering Committee for the British Hypertension Society's PATHWAY Programme of Trials Clinical Pharmacology Unit, University of Edinburgh, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Jackie Salsbury Clinical Pharmacology Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK PubMed articlesGoogle scholar articles
  • Steve Morant Medicines Monitoring Unit, Medical Research Institute, University of Dundee, Dundee, Tayside, UK PubMed articlesGoogle scholar articles
  • Ian Ford Trial Executive for the British Hypertension Society's PATHWAY Programme of Trials Steering Committee for the British Hypertension Society's PATHWAY Programme of Trials Robertson Centre, University of Glasgow, Glasgow, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Morris J Brown; morris.brown{at}cai.cam.ac.uk
View Full Text

Citation

Brown MJ, Williams B, MacDonald TM, et al
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension
BMJ Open 2015;5:e008086. doi: 10.1136/bmjopen-2015-008086

Publication history

  • Received March 2, 2015
  • Revised April 30, 2015
  • Accepted June 15, 2015
  • First published August 7, 2015.
Online issue publication 
October 25, 2017
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/